Mandate

Vinge advises Nolek Intressenter AB in connection with the sale of Nolek AB to Indutrade AB (publ.)

December 05, 2012

Vinge has advised Nolek Intressenter AB in connection with the sale of Nolek AB to Indutrade AB (publ.). Nolek is a leading producer of instruments and machines for leak testing, leak detection and proof testing. The company has production facilities in Sweden and Malaysia and sales companies in the US, Hungary and Denmark. The company’s customers include companies with international operations in a range of areas, including the automotive, pharmaceuticals, electronics and engineering industries.

Vinge’s team consisted of Jonas Bergström together with, among others, associates Alex Miler, Alexandra Kempe, Gustav Jönsson and Daniel Järmén as well as project assistant Sara Andersson.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024